Two Sigma Advisers’s Immunic IMUX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,718
| Closed | -$10.7K | – | 2477 |
|
|
2024
Q4 | $10.7K | Sell |
10,718
-41,000
| -79% | -$41K | ﹤0.01% | 2327 |
|
|
2024
Q3 | $85.3K | Buy |
51,718
+4,000
| +8% | +$6.6K | ﹤0.01% | 2180 |
|
|
2024
Q2 | $53K | Sell |
47,718
-125,600
| -72% | -$139K | ﹤0.01% | 2360 |
|
|
2024
Q1 | $229K | Buy |
173,318
+25,900
| +18% | +$34.2K | ﹤0.01% | 2170 |
|
|
2023
Q4 | $221K | Sell |
147,418
-170,300
| -54% | -$255K | ﹤0.01% | 2202 |
|
|
2023
Q3 | $467K | Sell |
317,718
-96,300
| -23% | -$142K | ﹤0.01% | 1813 |
|
|
2023
Q2 | $1.04M | Buy |
414,018
+13,700
| +3% | +$34.4K | ﹤0.01% | 1522 |
|
|
2023
Q1 | $596K | Sell |
400,318
-166,100
| -29% | -$247K | ﹤0.01% | 1873 |
|
|
2022
Q4 | $793K | Buy |
566,418
+419,200
| +285% | +$587K | ﹤0.01% | 1679 |
|
|
2022
Q3 | $465K | Buy |
147,218
+2,700
| +2% | +$8.53K | ﹤0.01% | 1871 |
|
|
2022
Q2 | $501K | Buy |
144,518
+12,800
| +10% | +$44.4K | ﹤0.01% | 1923 |
|
|
2022
Q1 | $1.49M | Sell |
131,718
-23,700
| -15% | -$268K | ﹤0.01% | 1419 |
|
|
2021
Q4 | $1.49M | Sell |
155,418
-9,800
| -6% | -$93.8K | ﹤0.01% | 1338 |
|
|
2021
Q3 | $1.46M | Buy |
165,218
+2,900
| +2% | +$25.7K | ﹤0.01% | 1421 |
|
|
2021
Q2 | $1.99M | Sell |
162,318
-30,600
| -16% | -$375K | 0.01% | 1302 |
|
|
2021
Q1 | $3.08M | Sell |
192,918
-8,500
| -4% | -$135K | 0.01% | 1062 |
|
|
2020
Q4 | $3.08M | Buy |
201,418
+82,400
| +69% | +$1.26M | 0.01% | 1048 |
|
|
2020
Q3 | $2.21M | Buy |
+119,018
| New | +$2.21M | 0.01% | 1110 |
|
|
2019
Q2 | – | Sell |
-91,200
| Closed | -$18K | – | 2371 |
|
|
2019
Q1 | $18K | Buy |
91,200
+5,100
| +6% | +$1.01K | ﹤0.01% | 2258 |
|
|
2018
Q4 | $16K | Buy |
86,100
+72,100
| +515% | +$13.4K | ﹤0.01% | 2316 |
|
|
2018
Q3 | $4K | Buy |
+14,000
| New | +$4K | ﹤0.01% | 2205 |
|